NDC 24571-123

REGIOCIT

Sodium Chloride, Sodium Citrate

REGIOCIT is a Extracorporeal Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is Sodium Chloride; Sodium Citrate, Unspecified Form.

Product ID24571-123_34cf38df-f4f8-4776-8c2f-0c89dadc0f64
NDC24571-123
Product TypeHuman Prescription Drug
Proprietary NameREGIOCIT
Generic NameSodium Chloride, Sodium Citrate
Dosage FormInjection, Solution
Route of AdministrationEXTRACORPOREAL
Marketing Start Date2020-09-18
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameBaxter Healthcare Corporation
Substance NameSODIUM CHLORIDE; SODIUM CITRATE, UNSPECIFIED FORM
Active Ingredient Strength5 g/1000mL; g/1000mL
Pharm ClassesAcidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 24571-123-02

2 BAG in 1 CARTON (24571-123-02) > 5000 mL in 1 BAG
Marketing Start Date2020-09-18
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [REGIOCIT]

Mark Image

Registration | Serial
Company
Trademark
Application Date
REGIOCIT
REGIOCIT
87294070 5305295 Live/Registered
GAMBRO LUNDIA AB
2017-01-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.